SearcharxivSearch

arXiv subjects

Diane Demailly

Publications and source records attributed to Diane Demailly.

3 recordsLinked to original sources

Simultaneous hyperkinetic movement disorders phenotyping: a cross-cohort pediatric transfer study using routine videos, markerless pose estimation and a tabular foundation model

Objective: To develop and externally test a video-based framework for simultaneous detection of hyperkinetic MDs phenomenologies: dystonia, tremor, myoclonus, chorea, athetosis, ballismus, stereotypies, and tics using routine clinical recordings, with explicit testing of external, cross-cohort transfer from adult to pediatric populations. Methods: In this proof-of-concept study, the framework combines markerless pose estimation, kinematic descriptors, and a pretrained fondation model. A shared predictive backbone was developed on 21 adults with confirmed hyperkinetic MDs and 4 healthy controls assessed under a standardized protocol. External validation was performed on an independent external cohort: a real-world pediatric sample (n=12, monogenic combined MDs). For the external dataset, the backbone was deployed without retraining; lightweight calibration adjusted only the final subject-level decision step using a small labeled subset of patients selected by clinicians as representative of the cohort's phenotypic range. Results: After local calibration of the decision layer on the clinician-selected subset, performance improved consistently on the held-out pediatric patients (n=7): Hamming accuracy rose from 0.804 to 0.839 and the Jaccard index from 0.548 to 0.633. This calibrated performance was preserved, and the Jaccard index further improved, when the evaluation was restricted to the phenomenologies with more definite clinician agreement (Hamming accuracy 0.9, Jaccard index 0.786), indicating that the gains did not rest on the least-reliable labels.

cs.CV

Deep Learning Pose Estimation for Multi-Label Recognition of Combined Hyperkinetic Movement Disorders

Hyperkinetic movement disorders (HMDs) such as dystonia, tremor, chorea, myoclonus, and tics are disabling motor manifestations across childhood and adulthood. Their fluctuating, intermittent, and frequently co-occurring expressions hinder clinical recognition and longitudinal monitoring, which remain largely subjective and vulnerable to inter-rater variability. Objective and scalable methods to distinguish overlapping HMD phenotypes from routine clinical videos are still lacking. Here, we developed a pose-based machine-learning framework that converts standard outpatient videos into anatomically meaningful keypoint time series and computes kinematic descriptors spanning statistical, temporal, spectral, and higher-order irregularity-complexity features.

cs.CV

Freezing of Gait as a Complication of Pallidal Deep Brain Stimulation in DYT- KMT2B Patients with Evidence of Striatonigral Degeneration

Background: Mutations in KMT2B are a recognized cause of early-onset complex dystonia, with deep brain stimulation (DBS) of the internal globus pallidus (GPi-DBS) being an effective treatment. However, gait impairment, particularly freezing of gait (FOG), remains a significant challenge in DYT-KMT2B patients post-DBS. Objectives: To characterize the emergence of FOG in DYT-KMT2B patients treated with GPi-DBS and explore potential underlying mechanisms, including striatonigral degeneration. Methods: Five patients (four females) with KMT2B-related dystonia and protein-truncating variants (PTVs) were retrospectively analyzed. Clinical progression, response to GPi-DBS, and the presence of FOG were documented. Dopaminergic function was assessed using DaTscan (SPECT for ^123I-ioflupane) in four patients. Results: FOG developed in all patients, with onset ranging from 1 to 15.5 years post-DBS. DaTscan abnormalities, indicative of bilateral striatal dopaminergic denervation, were observed in four cases. Prior to DBS, all patients exhibited dystonia unresponsive to L-dopa, and post-DBS, FOG remained refractory to dopaminergic treatment in most cases. Despite initial improvements in gait post-DBS, only one patient maintained independent ambulation at the last follow-up. Conclusions: FOG is an emerging complication in DYT-KMT2B patients with PTVs undergoing GPi-DBS, potentially linked to underlying striatonigral degeneration. The findings suggest a need for long-term motor surveillance and consideration of alternative therapeutic strategies, including dopaminergic trials, in this patient population. Further studies are required to elucidate the precise mechanisms driving DBS-related hypokinetic gait disturbances in DYT-KMT2B dystonia.

q-bio.NC